Hematologic toxicity of gemcitabine： a comparison between fixed-dose rate infusion and thirty-minute infusion in the treatment of malignancy.pdfVIP

Hematologictoxicityofgemcitabine：acomparison infusioninthetreatmentofmalignancy木 ChunyanLi，LiChu(Co—firstauthor)，HuiHan，XiLiu，YupingShen，MantangOju，QjngXu DepartmentofMedicalOncology，TenthPeople’sHospital，TongjiUniversity，Shanghai200072，China FirstClinicalCollegeofNanjingMedicalUniversity，Nanjing210029，China Received：2March2012／Revised：20March2012／Accepted：25April2012 @HuazhongUniversityofScienceandTechnologyandSpringer-VerlagBerlinHeidelberg2012 Abstract Objective：Theaimofthestudywastocomparelhehematoloqictoxicityofgemcitabinebetweenfixed—dose